Korean J Vet Res > Volume 63(1); 2023 > Article |
|
Treatment | Survival | Aggregation* | Blastocyst |
---|---|---|---|
Protease | 110/114 (96.0 ± 2.4) | 25/36 (69.2 ± 4.2)† | 18/25 (72.5 ± 5.1) |
Tyrode’s solution | 111/113 (97.9 ± 1.3) | 31/35 (88.3 ± 4.4)‡ | 23/30 (76.9 ± 2.5) |
Methods of blastomere aggregation | No. of cultured embryos* (aggregate†) | No. of embryos developed to (%) | Diameter of | ||
---|---|---|---|---|---|
Blastocyst | Embryo | TD2SEs | blastocysts (μm) | ||
Control (unaggregated) | 95 | 34 | 35.6 ± 4.8 | 147.4 ± 5.6॥ | |
Well-of-the-well‡ | 99 (33) | 19 | 58.1 ± 10.2 | 195.2 ± 19.2¶ | |
Phytohemagglutinin-L§ | 102 (34) | 18 | 52.2 ± 11.7 | 181.3 ± 12.8¶ |
Embryo type | No. of aggregated embryos (embryos)* | No. of blastocyst/aggregated embryo (%) | No. of cells in the blastocyst | Diameter of blastocyst (μm) |
---|---|---|---|---|
3P | 32 (96) | 29 (91.9 ± 5.8†) | 110.7 ± 7.4† | 306.9 ± 12.1† |
2P1N | 27 (81) | 20 (73.8 ± 9.5†,‡) | 92.8 ± 7.8†,‡ | 273.8 ± 12.1‡ |
1P2N | 25 (75) | 14 (56.2 ± 4.7‡) | 83.4 ± 11.5‡ | 229.6 ± 13.7§ |
3N | 31 (93) | 9 (24.3 ± 10.9§) | 66.0 ± 7.1‡ | 234.3 ± 24.1§ |
Joohyeong Lee
https://orcid.org/0000-0001-7233-6409
Lian Cai
https://orcid.org/0000-0002-1096-700X
Mirae Kim
https://orcid.org/0000-0002-5276-4374
Hyerin Choi
https://orcid.org/0000-0001-6320-456X
Dongjin Oh
https://orcid.org/0000-0002-4055-4361
Ali Jawad
https://orcid.org/0000-0002-9356-9997
Eunsong Lee
https://orcid.org/0000-0001-9654-7788
Sang-Hwan Hyun
https://orcid.org/0000-0001-6011-2555